Strategies for oral delivery and mitochondrial targeting of CoQ10.
Level 5 - mechanism / opinion, no new human data
Narrative review of delivery mechanisms and formulation strategies without original clinical data or systematic review methods.
PubMed 25544601 · doi:10.3109/10717544.2014.993747
What was done
This narrative review synthesized literature on the pharmacokinetic hurdles and delivery strategies for coenzyme Q10 (CoQ10). The authors evaluated barriers to oral absorption—including lipophilicity, large molecular weight, regional variations in gastrointestinal permeability, and multitransporter involvement—and summarized approaches to achieve intracellular and mitochondrial membrane targeting.
What was found
The abstract reports no quantitative values, comparative metrics, or statistical findings. It notes qualitatively that CoQ10 has low oral bioavailability and limited intracellular delivery, and summarizes delivery methods investigated to route the molecule to its functional site in the inner mitochondrial membrane.
Why it matters
CoQ10 is widely used as a therapeutic antioxidant and metabolic cofactor, but its cellular target is intracellular. Understanding and addressing delivery hurdles is essential for developing formulations that achieve physiologically meaningful concentrations inside mitochondria.
Limits
The abstract describes a narrative review without systematic search parameters, meta-analytic data, or new human clinical trials. No quantitative comparisons of delivery technologies or formulation bioavailabilities are provided in the abstract.
Cited by
- supports Coenzyme Q10 has low oral bioavailability.